Here, our study indicated that miR-18a-5p was significantly upregulated and miR-18a-5p repressed SOCS5 expression by directly targeting its 3′-UTR in CML cells. The gene discussed is SOCS5; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.